Message-ID: <7B2452542A5A433DA9B930C429E309DA@Francesco>
From: "Victoria Mullen" <clefspj18@rkraussrealtor.com>
To: <lojban@lojban.org>
Subject: Very simple
Date: Thu, 11 Sep 2014 23:17:17 +0100
MIME-Version: 1.0
Content-Type: text/plain;
	format=flowed;
	charset="iso-8859-1";
	reply-type=original
Content-Transfer-Encoding: 7bit
X-Spam_score: 1.1
X-Spam_score_int: 11
X-Spam_bar: +
X-Spam-Report: Spam detection software, running on the system "stodi.digitalkingdom.org", has
 identified this incoming email as possible spam.  The original message
 has been attached to this so you can view it (if it isn't spam) or label
 similar future email.  If you have any questions, see
 the administrator of that system for details.
 
 Content preview:  Very simple, you can take two capsules daily with food and
    water, one before breakfast andone before lunch, thats it - www.mecadestop.com
    ------ [...] 
 
 Content analysis details:   (1.1 points, 5.0 required)
 
  pts rule name              description
 ---- ---------------------- --------------------------------------------------
  0.4 STOX_REPLY_TYPE        STOX_REPLY_TYPE
 -1.9 BAYES_00               BODY: Bayes spam probability is 0 to 1%
                             [score: 0.0034]
  1.8 STOX_REPLY_TYPE_WITHOUT_QUOTES STOX_REPLY_TYPE_WITHOUT_QUOTES
  0.8 RDNS_NONE              Delivered to internal network by a host with no rDNS

Very simple, you can take two capsules daily with food and water, one before breakfast andone before lunch, thats it - 

www.mecadestop.com

------


Study authors focused on records from one Canadian hospital. In the six months prior to Angelina's revelation that she carried the BRCA1 mutation (which leads to a higher risk of breast and ovarian cancer), 487 women were referred for genetic testing. In the six months after her announcement, 916 women were referred.

It may be that both women and doctors who heard Jolie’s story contributed to this 90 percent increase, note the researchers. According to this study, the number of women who qualified for genetic testing doubled, as did the number of women found to be BRCA1 mutation carriers, plus those who had another breast- and ovarian-cancer linked gene, BRCA2.

"While this is a small study, it shows the profound impact that prominent figures like Jolie can have on public awareness of health issues," said lead study author Jacques Raphael, M.D., clinical fellow at Sunnybrook Odette Cancer Centre in Toronto, Canada, in a statement.


Now, over a year later, researchers are revealing just how her public announcement has changed the way women take charge of their health. In fact, researchers attribute a surge in the number of women being referred for genetic testing to this "Angelina Effect," according to a yet-to-be-published study presented at the 2014 American Society of Clinical Oncology Breast Cancer Symposium.